Cargando…

Systemic ALK‐positive anaplastic large cell lymphoma with bilateral optic neurolymphomatosis resulting in permanent blindness

ALK‐positive ALCL can lead to rapid irreversible destruction of the optic pathway. Early treatment should be instituted in patients with CNS involvement or those at increased CNS risk.

Detalles Bibliográficos
Autores principales:	Seegobin, Karan, Alhaj Moustafa, Muhamad, Fischer, Deborah, Keller, Katelyn, Hastings, Jacquelyn, Kharfan‐Dabaja, Mohamed A., Ayala, Ernesto, Gupta, Vivek, Tun, Han W., Jiang, Liuyan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Case Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7752471/ https://www.ncbi.nlm.nih.gov/pubmed/33363793 http://dx.doi.org/10.1002/ccr3.3231

Ejemplares similares

Successful treatment of IgG4‐related hypertrophic pachymeningitis with induction rituximab and dexamethasone followed by maintenance rituximab
por: Seegobin, Karan, et al.
Publicado: (2021)

Successful Non-Transplant Treatment of Double Hit Richter Transformation with Long-Term Remission
por: Seegobin, Karan, et al.
Publicado: (2021)

Primary diffuse large B‐cell lymphoma presenting as acute appendicitis: A report of 2 cases and a literature review
por: Fernandez Turizo, Maria Jose, et al.
Publicado: (2020)

Intravascular Large B Cell Lymphoma with CNS Involvement Successfully Treated with High-Dose Methotrexate and High-Dose Ara-C Based CNS-Directed Chemoimmunotherapy Alternating with Anthracycline Based Chemoimmunotherapy
por: Wang, Jing, et al.
Publicado: (2022)

Macrophage Activation Led Acute Heart Failure Managed Successfully with Immunosuppression
por: Seegobin, Karan, et al.
Publicado: (2021)

Clinical characteristics, prognostic indicators, and survival outcomes in intravascular lymphoma: Mayo Clinic experience (2003–2018)
por: Seegobin, Karan, et al.
Publicado: (2022)

Primary Cauda Equina Lymphoma Treated with CNS-Centric Approach: A Case Report and Literature Review
por: Kuhlman, Justin J, et al.
Publicado: (2021)

Primary HHV-8 (-) Effusion-Based Non-Germinal Center B Cell Diffuse Large B Cell Lymphoma Successfully Treated with Standard Anthracycline-Based Chemoimmunotherapy
por: Kuhlman, Justin, et al.
Publicado: (2021)

Long-Term Survival with Ibrutinib Therapy in Elderly Patients with Newly Diagnosed Primary Central Nervous System Lymphoma
por: Kuhlman, Justin J, et al.
Publicado: (2022)

Successful CNS-Centric Therapeutic Management and Genomic Profiling of Primary Cranial Vault Diffuse Large B-Cell Lymphoma
por: Davis, Jordan, et al.
Publicado: (2023)

Primary age‐related EBV‐associated effusion‐based lymphoma successfully treated with rituximab and thoracentesis
por: Kuhlman, Justin J., et al.
Publicado: (2021)

Neurolymphomatosis in a cat
por: SAKURAI, Masashi, et al.
Publicado: (2016)

Ocular involvement in neurolymphomatosis
por: Liu, Katy C., et al.
Publicado: (2018)

The Diagnostic Dilemma of Neurolymphomatosis
por: Shree, Ritu, et al.
Publicado: (2016)

BRAF p.V600E associated poly-neoplastic syndrome
por: Alhaj Moustafa, Muhamad, et al.
Publicado: (2021)

Primary Bone Marrow Lymphoma: De Novo and Transformed Subtypes
por: Kimbrough, ErinMarie O, et al.
Publicado: (2022)

Lymphoma relapse presenting as neurolymphomatosis
por: Pham, My, et al.
Publicado: (2016)

Evolution of Neurolymphomatosis to Lymphomatosis Cerebri
por: Chang, Gregory Youngnam
Publicado: (2017)

Ultrasonography Aids in the Diagnosis of Neurolymphomatosis
por: Taniguchi, Tomohiko, et al.
Publicado: (2022)

Neurolymphomatosis: A Surreal Presentation of Lymphoma
por: Khandelwal, Shikha, et al.
Publicado: (2017)

(90)Yttrium Ibritumomab Tiuxetan (Zevalin) for the Treatment of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Report of 5 Cases
por: Wang, Jing, et al.
Publicado: (2023)

Immune Response against ALK in Children with ALK-Positive Anaplastic Large Cell Lymphoma
por: Stadler, Serena, et al.
Publicado: (2018)

Holistic View of ALK TKI Resistance in ALK-Positive Anaplastic Large Cell Lymphoma
por: Wang, Yuan, et al.
Publicado: (2022)

Novel covalent modification of human anaplastic lymphoma kinase (ALK) and potentiation of crizotinib-mediated inhibition of ALK activity by BNP7787
por: Parker, Aulma R, et al.
Publicado: (2015)

Pathobiology of ALK-negative anaplastic large cell lymphoma
por: Pileri, Stefano A., et al.
Publicado: (2011)

ALK-positive anaplastic large cell lymphoma in adults
por: Gromowsky, Matthew J, et al.
Publicado: (2023)

Neurolymphomatosis mimicking neurosarcoidosis: a case report
por: Santos, Ernestina, et al.
Publicado: (2010)

Neurolymphomatosis: role of positron emission tomography in diagnosis
por: Cheung, Carol, et al.
Publicado: (2011)

Neurolymphomatosis in the Cauda Equina Diagnosed by an Open Biopsy
por: Sasaki, Ryo, et al.
Publicado: (2018)

Neurolymphomatosis in Intravascular Large B-cell Lymphoma
por: Miyajima, Toru, et al.
Publicado: (2022)

An Exploration into the Origins and Pathogenesis of Anaplastic Large Cell Lymphoma, Anaplastic Lymphoma Kinase (ALK)-Positive
por: Turner, Suzanne D.
Publicado: (2017)

Comparable Efficacy of Reduced Dose Radiation Therapy for the Treatment of Early Stage Gastric Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue
por: Saifi, Omran, et al.
Publicado: (2021)

Atypical Carcinoid Tumor with Anaplastic Lymphoma Kinase (ALK) Rearrangement Successfully Treated by an ALK Inhibitor
por: Nakajima, Masayuki, et al.
Publicado: (2016)

Targeting Anaplastic Lymphoma Kinase (ALK) in Rhabdomyosarcoma (RMS) with the Second-Generation ALK Inhibitor Ceritinib
por: van Erp, Anke E. M., et al.
Publicado: (2017)

Primary Anaplastic Lymphoma Kinase (ALK)-Negative Anaplastic Large Cell Lymphoma (ALCL) Presenting as Perforation Peritonitis: A Case Report and Management Principles
por: Sanker, Vivek, et al.
Publicado: (2022)

ALK Signaling and Target Therapy in Anaplastic Large Cell Lymphoma
por: Tabbó, Fabrizio, et al.
Publicado: (2012)

Educational Case: ALK-Negative Anaplastic Large Cell Lymphoma
por: Satou, Akira, et al.
Publicado: (2020)

Precision therapy with anaplastic lymphoma kinase inhibitor ceritinib in ALK-rearranged anaplastic large cell lymphoma
por: Subbiah, V., et al.
Publicado: (2021)

Development of anaplastic lymphoma kinase (ALK) inhibitors and molecular diagnosis in ALK rearrangement-positive lung cancer
por: Iwama, Eiji, et al.
Publicado: (2014)

Alectinib, an Anaplastic Lymphoma Kinase Inhibitor, Abolishes ALK Activity and Growth in ALK-Positive Neuroblastoma Cells
por: Alam, Muhammad Wasi, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_me60gbugujv7ap3n933pp6lk8l